lipiodol ultra fluid 480 mg/ml injektionsvæske, opløsning
2care4 aps - joderet olie - injektionsvæske, opløsning - 480 mg/ml
lymelysal 300 mg kapsler, hårde
2care4 generics aps - lymecyclin - kapsler, hårde - 300 mg
numeta g16e infusionsvæske, emulsion
baxter a/s - alanin, arginin, asparaginsyre, calciumchloriddihydrat, cystein, glucosemonohydrat, glutaminsyre, glycin, histidin, isoleucin, kaliumacetat, leucin, lysinmonohydrat, magnesiumacetattetrahydrat, methionin, natriumchlorid, natriumglycerophosphat, hydreret, olivenolie, renset, ornithinmonohydrochlorid, phenylalanin, prolin, serin, soyaolie, renset, taurin, threonin, tryptophan, tyrosin, valin - infusionsvæske, emulsion
numeta g19e infusionsvæske, emulsion
baxter a/s - alanin, arginin, asparaginsyre, calciumchloriddihydrat, cystein, glucosemonohydrat, glutaminsyre, glycin, histidin, isoleucin, kaliumacetat, leucin, lysinmonohydrat, magnesiumacetattetrahydrat, methionin, natriumchlorid, natriumglycerophosphat, hydreret, olivenolie, renset, ornithinmonohydrochlorid, phenylalanin, prolin, serin, soyaolie, renset, taurin, threonin, tryptophan, tyrosin, valin - infusionsvæske, emulsion
finomel infusionsvæske, emulsion
baxter a/s - alanin, arginin, calciumchloriddihydrat, fiskeolie, glucosemonohydrat, glycin, histidin, isoleucin, kaliumchlorid, leucin, lysinhydrochlorid, magnesiumsulfatheptahydrat, methionin, natriumacetattrihydrat, natriumglycerophosphat, hydreret, olivenolie, renset, phenylalanin, prolin, serin, soyaolie, threonin, triglycerider, middelkædelængde, tryptophan, tyrosin, valin, zinksulfat heptahydrat - infusionsvæske, emulsion
finomel perifer infusionsvæske, emulsion
baxter a/s - alanin, arginin, calciumchloriddihydrat, fiskeolie, glucosemonohydrat, glycin, histidin, isoleucin, kaliumchlorid, leucin, lysinhydrochlorid, magnesiumsulfatheptahydrat, methionin, natriumacetattrihydrat, natriumglycerophosphat, hydreret, olivenolie, renset, phenylalanin, prolin, serin, soyaolie, threonin, triglycerider, middelkædelængde, tryptophan, tyrosin, valin, zinksulfat heptahydrat - infusionsvæske, emulsion
numeta g13e infusionsvæske, emulsion
baxter a/s - alanin, arginin, asparaginsyre, cystein, glutaminsyre, glycin, histidin, isoleucin, leucin, lysinmonohydrat, methionin, ornithinmonohydrochlorid, phenylalanin, prolin, serin, taurin, threonin, tryptophan, tyrosin, valin - infusionsvæske, emulsion
lojuxta
amryt pharmaceuticals dac - lomitapide - hyperkolesterolæmi - lipid modificerende midler - lojuxta er indiceret som et supplement til en low‑fat kost og andre lipid‑lowering lægemidler med eller uden lav density lipoprotein (ldl) aferese hos voksne patienter med homozygot familiær hyperkolesterolæmi (hofh). genetiske bekræftelse af hofh skal indhentes, når det er muligt. andre former for primær hyperlipoproteinaemia og sekundære årsager til hypercholesterolaemia e. nefrotisk syndrom, hypothyroidisme) skal udelukkes,.
bindren
mitsubishi pharma europe ltd - colestilan - hyperfosfatæmi - lægemidler til behandling af hyperkaliæmi og hyperphosphatæmi - behandling af hyperphosphatæmi hos voksne patienter med kronisk nyresygdom, fase 5, der modtager hæmodialyse eller peritonealdialyse.
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.